Objective. Pulmonary hypertension (PH ) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH.
Scleroderma, or systemic sclerosis (SSc), is a generalized endothelial cell antibodies, has also been shown to be connective tissue disease which is characterized by micpredictive of IPH [7] . Other studies have shown that rovascular obliteration and increased deposition of colthe nitric oxide concentration in exhaled air is decreased lagen, resulting in fibrotic lesions [1, 2] . Pulmonary [8] . In order to identify the common features of SSc involvement is a common feature of SSc, and pulmonary patients with PH, we carried out Doppler echocardiograhypertension (PH ) is a frequent cause of death in SSc phy, other multiple cardiopulmonary tests and laboratpatients [3] [4] [5] . PH can be due primarily to pulmonary ory examination. vascular abnormalities or can be secondary to cardiac or interstital lung involvement. The former is regarded as isolated pulmonary hypertension (IPH ) and is usually found in patients with limited cutaneous SSc and minPatients and methods imal or no pulmonary fibrosis [3, 4] . In contrast, patients with diffuse cutaneous SSc may develop PH due to Clinical assessment severe pulmonary fibrosis, but this is uncommon [4] .
All 125 patients with SSc who were evaluated in our Many clinical and laboratory features of SSc patients clinic between 1990 and 1999 were included in the study. with PH have been reported to date. An isolated reducPatients with SSc were grouped according to the classition in diffusion capacity for carbon monooxidase is fication system proposed by LeRoy et al. [9] : 55 patients associated with an increased risk of IPH [5] . We have had diffuse cutaneous SSc (dcSSc) and 70 patients had reported that anti-cardiolipin b2-glycoprotein I antibody limited cutaneous SSc ( lcSSc), as described previously was significantly correlated with the presence of IPH [6 ] . All patients fulfilled the criteria proposed by the [6 ] . Table 1 . There was no significant difference severity of pulmonary fibrosis (PF ), the patients were divided into three groups [4, 11] : (i) patients with between these groups in sex, age, or duration of the disease. Fourteen patients had IPH; five patients had isolated PH (IPH; PH without severe PF ); (ii) patients with secondary PH (SPH; PH with severe PF ); and (iii) dcSSc and nine patients had lcSSc. All of these patients had IPH without other antecedent pulmonary or cardiac patients without PH. Patients with severe pulmonary fibrosis seen on radiographs or restrictive disease conditions. Six patients had SPH; five patients had dcSSc and one patient had lcSSc. All of these patients revealed by a pulmonary function test (vital capacity <70% of predicted) were considered to have PH secondhad severe pulmonary fibrosis. The incidence of pitting scars/ulcers was significantly greater in the patients with ary to pulmonary causes. All remaining patients with PH were considered to have primary pulmonary disease SPH than in those without PH (100 vs 49%, P < 0.05). Anti-topoisomerase I antibody was found in a signifior isolated pulmonary hypertension.
cantly greater proportion of the patients with SPH Statistical analysis than of those with IPH and of those without PH (83 vs 14%, P < 0.01 and 83 vs 32%, P < 0.02, respectively). The Mann-Whitney test was used to compare means and Fisher's exact probability test for the analysis of An elevated erythrocyte sedimentation rate ( ESR) and increased immunoglobulin G (IgG ) were found in a frequency. Correlations with clinical data were assessed by Spearman's rank correlation coefficient. Two-tailed significantly greater proportion of the patients with SPH than of those without PH (100 vs 49%, P < 0.02 and 67 P values less than 0.05 were considered significant. Unless noted otherwise, values are percentages of patients. U1RNP, U1 ribonucleoproteins. aP < 0.0001, bP < 0.001, cP < 0.01, dP < 0.02, eP < 0.05 vs patients without PH.
vs 24%, P < 0.05, respectively). In addition, elevated tended to have pitting scars/ulcers. We conclude that these features are common in SSc patients with PH. ESR and increased IgG were found in a significantly greater proportion of the patients with IPH than of those without PH (100 vs 49%, P < 0.02 and 67 vs 24%, References P < 0.05, respectively). significant differences in the levels of serum IgA and Chest 1997; 111:36-43. IgM among the different subgroups (data not shown). In this cross-sectional study, we have shown that 14. Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary elevated ESR and increased IgG were common in SSc hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996; 35:989-93. patients with PH. Moreover, SSc patients with SPH
